Middlebrook Gets $100M and a New Management Team Nov. 1, 2011 By Tiffany Turner No Comments No AbstractRead More
IDM Pleased with Data from Osteosarcoma Program Nov. 1, 2011 By Tiffany Turner No Comments No AbstractRead More
LigoCyte Sets Series C Terms: $28M for Vaccine Development Nov. 1, 2011 By Tiffany Turner No Comments No AbstractRead More
NewCo News: Cortria Aims to Capitalize on Dyslipidemia Market July 21, 2008 By Tiffany Turner No Comments
BioAlliance Stops Doxorubicin Trial After Pulmonary Reactions July 17, 2008 By Tiffany Turner No Comments
Avastin, Tarceva Sales Boost Genentech's Quarterly Earnings July 16, 2008 By Tiffany Turner No Comments
Big Pharmas Team Up to Link Technology and Business Needs July 11, 2008 By Tiffany Turner No Comments
